Breaks Categories: News

FridayNov 01, 2024 9:35 am

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Granted Nasdaq Extension for Compliance

CNS Pharmaceuticals (NASDAQ: CNSP) announced that it received an exception from the Nasdaq Hearings Panel, granting the company until March 11, 2025, to meet the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). This extension allows CNS additional time to regain compliance and maintain its listing status. To view the full press release, visit https://nnw.fm/XfYXS About CNS Pharmaceuticals Inc. CNS Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system. The company’s lead drug candidate, Berubicin, is a novel anthracycline and…

Continue Reading

FridayNov 01, 2024 9:00 am

NetworkNewsBreaks – SOBRsafe Inc. (NASDAQ: SOBR) Secures Nasdaq Compliance, Continues Listing Under Monitoring Period

SOBRsafe (NASDAQ: SOBR) announced its compliance with Nasdaq's listing standards, meeting minimum bid price, public float, and stockholders' equity requirements per the August 2024 Nasdaq Hearings Panel decision. As a result, SOBRsafe's common stock will remain listed on the Nasdaq Capital Market. The company will undergo a one-year monitoring period starting Oct. 30, 2024, during which any recurrence of non-compliance with the stockholders' equity rule will result in an immediate Delist Determination Letter, requiring a new hearing request without a compliance grace period. To view the full press release, visit https://nnw.fm/8USxt About SOBRsafe(TM) Alcohol misuse is the fourth leading cause…

Continue Reading

ThursdayOct 31, 2024 12:12 pm

NetworkNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Strengthens Board with Key Appointments

D-Wave Quantum (NYSE: QBTS) (“D-Wave”) has appointed technology leaders John DiLullo, CEO of Deepwatch, and Rohit Ghai, CEO of RSA, to its board of directors as the company executes an aggressive go-to-market strategy designed to drive the rapid adoption of its annealing quantum computing solutions across global businesses, research institutions and government agencies. DiLullo and Ghai bring extensive expertise in accelerating growth and profitability, commercial technology adoption, and digital transformation. Their additions are strategically timed as D-Wave looks to leverage growth opportunities in fields like AI, logistics, and material science, underscoring its leadership in quantum computing. To view the full…

Continue Reading

ThursdayOct 31, 2024 11:45 am

NetworkNewsBreaks – Trump Media & Technology Group Corp. (NASDAQ: DJT) Faces Significant Stock Decline

Trump Media & Technology Group (NASDAQ: DJT) is facing a notable decline in its stock value, with shares dropping over 16% on Wednesday. This marks the largest percentage decrease in six months, halting the stock’s recent upward trend. The company, known for its social media platform, competes with major players like Twitter and Facebook. The current price of DJT is $38.27, showing a decrease of 4.40% or $1.76. This decline is part of a broader fluctuation, with the stock trading between $37.60 and $43.86 today. Such volatility is not uncommon in the tech sector, where market sentiment can shift rapidly.…

Continue Reading

ThursdayOct 31, 2024 9:53 am

NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) to Spotlight Innovative I&I Pipeline and CDMO Services at BIO-Europe 2024

Scinai Immunotherapeutics (NASDAQ: SCNI) will showcase its inflammation and immunology (“I&I”) product pipeline and contract development and manufacturing (“CDMO”) services at the BIO-Europe 2024 conference in Stockholm from November 4-6. CEO Amir Reichman and CTO Dr. Dalit Weinstein-Fischer will meet with potential clients, pharma partners and investors to discuss co-development opportunities in I&I, collaborations in dermatology, particularly for their Botox-like psoriasis treatment and Scinai’s CDMO capabilities. Scinai will also exhibit at booth #150, where interested parties can learn more about their end-to-end biologics services. To view the full press release, visit https://nnw.fm/y6S2z About Scinai Immunotherapeutics Ltd. Scinai is a biopharmaceutical…

Continue Reading

ThursdayOct 31, 2024 9:15 am

NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) to Host Q3 Earnings Call with Key Regulatory and Initiative Updates

HeartBeam (NASDAQ: BEAT), a medical technology company focused on enhancing cardiac care through advanced insights, will hold a conference call on November 7, 2024, at 4:30 p.m. ET to discuss third-quarter results and share updates on regulatory developments and ongoing projects. CEO Robert Eno, Founder and President Dr. Branislav Vajdic, and CFO Timothy Cruickshank will lead the call, which will include a Q&A session and a presentation accessible via the company’s investor relations page. A press release with detailed Q3 results will be released prior to the call. To view the full press release, visit https://nnw.fm/Xl4XA About HeartBeam Inc. HeartBeam…

Continue Reading

ThursdayOct 31, 2024 9:10 am

NetworkNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) CEO Details Promising Phase 3 Path for Alzheimer’s Treatment on The BioMedWire Podcast

Annovis Bio (NYSE: ANVS) led by Founder, President and CEO Dr. Maria Maccecchini, shares exciting developments regarding its pioneering Alzheimer’s and Parkinson’s drug candidate, buntanetap. In her interview on IBN’s BioMedWire Podcast, Dr. Maccecchini discusses Annovis Bio’s recent FDA clearance to proceed with pivotal Phase 3 trials for early-stage Alzheimer’s patients, a critical step toward potential market approval. Highlighting buntanetap’s unique mechanism that targets multiple neurotoxic proteins, Dr. Maccecchini explains the potential for superior outcomes compared to existing therapies, emphasizing the drug’s demonstrated short-term efficacy and differentiated approach in neurodegenerative treatment. To view the full press release, visit https://nnw.fm/sn0n6 About…

Continue Reading

WednesdayOct 30, 2024 3:45 pm

NetworkNewsBreaks – PayPal Holdings Inc.’s (NASDAQ: PYPL) Strategic Shift and Market Performance

  PayPal Holdings (NASDAQ: PYPL) is a leading player in the digital payments industry, known for its innovative solutions that facilitate online transactions. Originally a pioneer in peer-to-peer payments, PayPal is now focusing on becoming a comprehensive two-sided payments technology platform. This strategic shift is crucial as the company faces challenges with slowing transaction growth rates. In its Q3 earnings call, PayPal reported a 9% increase in transaction volume. Despite this growth, the company has adjusted its revenue projections for the rest of the year, indicating they have fallen short of expectations. This adjustment reflects the challenges PayPal faces in…

Continue Reading

WednesdayOct 30, 2024 1:55 pm

NetworkNewsBreaks – Cannabis Means Business Event to Debut in New York, Marking Evolution of Global Cannabis Industry Dialogue

Cannabis Means Business (“CMB”), the rebranded successor to CWCBExpo, will hold its inaugural show on June 4-5, 2025, at New York’s Javits Center. This revamped platform is designed to foster critical discussions on the cannabis sector’s integration into mainstream business practices, attracting industry professionals, investors, policymakers, and key stakeholders. CMB aims to support the growth of New York as a global cannabis hub by providing expanded educational sessions and networking opportunities, focusing on topics such as market trends, regulatory frameworks, and best practices. The conference will spotlight the industry’s evolution through case studies and strategic insights, positioning attendees to capitalize…

Continue Reading

WednesdayOct 30, 2024 11:28 am

NetworkNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Subsidiary Expands West Coast Footprint with First Bollinger B4 EV Truck Deliveries

Mullen Automotive (NASDAQ: MULN) has announced that its subsidiary, Bollinger Motors, has delivered three Bollinger B4 electric trucks to TEC Equipment locations across Washington and California. The 2025 Bollinger B4, an all-electric Class 4 chassis cab truck built for commercial use, aims to support fleet electrification efforts on the West Coast, marking a milestone with TEC Equipment as a new dealer. These deliveries reflect a significant revenue contribution to Mullen’s fiscal quarter ending December 2024. The B4 model qualifies for up to $100,000 in federal and state tax incentives, strengthening Bollinger’s position in the EV commercial truck market and building…

Continue Reading